Defining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichment

Biomarkers in Medicine

Volumn 9, Issue 9, 2015, Pages 835-844

  Song, Ehwang ^a   Mechref, Yehia ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

cancer biomarkers; click chemistry enrichment; glycoprotein enrichment; glycoproteomics; HILIC enrichment; hydrazide chemistry; immunoaffinity based enrichment; LC MS MS; lectin chromatography

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CANCER BIOMARKER; CERULOPLASMIN; FIBROTECTIN 1 ISOFORM 2; GAMMA GLUTAMYL HYDROLASE; GLYCOPROTEIN; HAPTOGLOBIN; HERMES ANTIGEN; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 3; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 4; LEUCINE RICH ALPHA 2 GLYCOPROTEIN; MUCIN 1; NAPSIN A; PLASMA KALLIKREIN PRECURSOR; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; PROTHROMBIN; SYNDECAN 1; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; TUMOR MARKER;

BREAST CANCER; CLICK CHEMISTRY; DISEASE ASSOCIATION; DISEASE MARKER; ESOPHAGEAL ADENOCARCINOMA; GLYCOPROTEIN ENRICHMENT; GLYCOPROTEOMICS; HUMAN; HYDRAZIDE CHEMISTRY BASED ENRICHMENT; HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHIC ENRICHMENT; IMMUNOAFFINITY GLYCOPROTEIN ENRICHMENT; LECTIN AFFINITY ENRICHMENT; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LUNG CANCER; MASS SPECTROMETRY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION; TANDEM MASS SPECTROMETRY; METABOLISM; NEOPLASM; PROCEDURES;

BIOMARKERS, TUMOR; GLYCOPROTEINS; HUMANS; MASS SPECTROMETRY; NEOPLASMS;

EID: 84942885682     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.15.55     Document Type: Review

References (28)

1. Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13, 7, 448-462 (2012).
2. Mechref Y, Hu Y, Garcia A, Hussein A. Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis 33, 12, 1755-1767 (2012).
3. Hart GW, Copeland RJ. Glycomics hits the big time. Cell 143, 5, 672-676 (2010).
4. Madera M, Mann B, Mechref Y, Novotny MV. Efficacy of glycoprotein enrichment by microscale lectin affinity chromatography. J. Sep. Sci. 31(14), 2722-2732 (2008).
5. Vector Laboratories. www.vectorlabs.com
6. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 6, 660-666 (2003).
7. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 1, 9-29 (2014).
8. Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7, 23, 4292-4302 (2007).
9. Hongsachart P, Huang-Liu R, Sinchaikul S et al. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 30, 7, 1206-1220 (2009).
10. Zeng X, Hood BL, Sun M et al. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 9, 12, 6440-6449 (2010).
11. Li QK, Shah P, Li Y et al. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. J. Proteome Res. 12, 8, 3689-3696 (2013).
12. Tsai HY, Boonyapranai K, Sriyam S et al. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics. 11, 11, 2162-2170 (2011).
13. Wang D, Hincapie M, Rejtar T, Karger BL. Ultrasensitive characterization of site-specific glycosylation of affinity-purified haptoglobin from lung cancer patient plasma using 10 mum i.d. porous layer open tubular liquid chromatography-linear ion trap collision-induced dissociation/electron transfer dissociation mass spectrometry. Anal. Chem. 83, 6, 2029-2037 (2011).
14. Yang Z, Harris LE, Palmer-Toy DE, Hancock WS. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin. Chem. 52(10), 1897-1905 (2006).
15. Wang Y, Ao X, Vuong H et al. Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. J. Proteome Res. 7(10), 4313-4325 (2008).
16. Whelan SA, Lu M, He J et al. Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J. Proteome Res. 8, 8, 4151-4160 (2009).
17. Chen J, Xi J, Tian Y, Bova GS, Zhang H. Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens. Proteomics 13, 15, 2268-2277 (2013).
18. Yang L, Nyalwidhe JO, Guo S, Drake RR, Semmes OJ. Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol. Cell Proteomics 10(6), doi:10.1074/mcp.M110.007294 (2011) (Epub ahead of print).
19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61, 2, 69-90 (2011).
20. Qin X, Chen Q, Sun C et al. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques. Med. Oncol. 30(1), 420 (2013).
21. Ishihara T, Fukuda I, Morita A et al. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. J. Proteomics 74(10), 2159-2168 (2011).
22. Chen R, Tan Y, Wang M et al. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol. Cell Proteomics 10(7), doi:10.1074/mcp. M110.006445 (2011) (Epub ahead of print).
23. Li X, Jiang J, Zhao X et al. N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry. PLoS ONE 8, 12, e81921 (2013).
24. Song E, Zhu R, Hammoud ZT, Mechref Y. LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography. J. Proteome Res. 13, 11, 4808-4820 (2014).
25. Mayampurath A, Song E, Mathur A et al. Label-free glycopeptide quantification for biomarker discovery in human sera. J. Proteome Res. 13, 11, 4821-4832 (2014).
26. Song E, Pyreddy S, Mechref Y. Quantification of glycopeptides by multiple reaction monitoring liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 26, 17, 1941-1954 (2012).
27. Debruyne EN, Vanderschaeghe D, Van Vlierberghe H, Vanhecke A, Callewaert N, Delanghe JR. Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin. Chem. 56, 5, 823-831 (2010).
28. Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H. Computational framework for identification of intact glycopeptides in complex samples. Anal. Chem. 86, 1, 453-463 (2014).